 |
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
2015 News Releases
Dec. 30, 2015 - Third Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation by REVOKING CONSENT on Puma's BLUE Consent Revocation Card
Read
Dec. 29, 2015 - Second Leading Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation by REVOKING CONSENT on Puma's BLUE Consent Revocation Card
Read
Dec. 23, 2015 - ISS Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation by REVOKING CONSENT on Puma's BLUE Consent Revocation Card
Read
Dec. 18, 2015 - Puma Biotechnology Expands Third Cohort in Phase II Trial of PB272 in HER2 Mutation Positive Cancer Patients
Read
Dec. 16, 2015 - Puma Biotechnology to Host Conference Call to Discuss Loperamide Prophylaxis to Reduce Neratinib-Related Diarrhea
Read
Dec. 11, 2015 - Puma Biotechnology Presents 3-Year Disease Free Survival Data from Phase III Trial of PB272 in Extended Adjuvant Breast Cancer (ExteNET Trial) at the 2015 San Antonio Breast Cancer Symposium
Read
Dec. 10, 2015 - Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2015 San Antonio Breast Cancer Symposium
Read
Dec. 10, 2015 - Puma Biotechnology Announces Results of Phase II Trial of PB272 in Neoadjuvant Treatment of HER2-Positive Locally Advanced Breast Cancer
Read
Nov. 30, 2015 - Puma Biotechnology Provides Update from Meeting with European Medicines Agency
Read
Nov. 13, 2015 - Puma Biotechnology to Present Data at the San Antonio
Breast Cancer Symposium (SABCS)
Read
Nov. 9, 2015 - Puma Biotechnology Reports Third Quarter 2015 Financial Results
Read
Nov. 3, 2015 - Puma Biotechnology to Present at Credit Suisse Healthcare Conference
Read
Sept. 26, 2015 - Puma Biotechnology Announces Presentation of Phase III Trial of PB272 in Extended Adjuvant Breast Cancer (ExteNET Trial) in Centrally Confirmed HER2-Positive Early Stage Breast Cancer Patients
Read
Sept. 10, 2015 - Puma Biotechnology Announces Publication of PB272 in HER2 Non-Amplified Metastatic Breast Cancer with a HER2 mutation
Read
Aug. 10, 2015 - Puma Biotechnology Reports Second Quarter 2015 Financial Results
Read
June 4, 2015 - Puma Biotechnology to Present at Goldman Sachs Healthcare Conference
Read
June 1, 2015 - Puma Biotechnology Announces Phase III Trial of PB272 in Extended Adjuvant Breast Cancer (ExteNET Trial) Demonstrates Statistically Significant Improvement in Disease Free Survival
Read
May 27, 2015 - Puma Biotechnology to Present at Jefferies 2015 Healthcare Conference
Read
May 13, 2015 - Puma Biotechnology Announces Publication of Abstracts for the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting
Read
May 12, 2015 - Puma Biotechnology to Participate in Fireside Chat at UBS Global Healthcare Conference
Read
May 11, 2015 - Puma Biotechnology Reports First Quarter 2015 Financial Results
Read
May 6, 2015 - Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference
Read
April 30, 2015 - Puma Biotechnology to Present at Deutsche Bank Health Care Conference
Read
April 14, 2015 - Puma Biotechnology Expands Cohort in Phase II Trial of PB272 in HER2 Mutation Positive Cancer Patients
Read
Mar. 10, 2015 - Puma Biotechnology Initiates Phase II Trial of PB272 in Early Stage HER2-Positive Breast Cancer
Read
Mar. 2, 2015 - Puma Biotechnology Reports Fourth Quarter and Full Year 2014 Financial Results
Read
Feb. 24, 2015 - Puma Biotechnology to Present at Cowen Health Care Conference
Read
Feb. 18, 2015 - Puma Biotechnology to Participate in Fireside Chat at RBC Capital Markets’ Global Healthcare Conference
Read
Feb. 5, 2015 - Puma Biotechnology to Present at Leerink Global Healthcare Conference
Read
Jan. 27, 2015 - Puma Biotechnology Closes $218 Million Public Offering of Common Stock
Read
Jan. 22, 2015 - Puma Biotechnology Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares
Read
Jan. 21, 2015 - Puma Biotechnology Prices Public Offering of Common Stock
Read
Jan. 20, 2015 - Puma Biotechnology Announces Proposed Public Offering
Read
Jan. 5, 2015 - Puma Biotechnology to Present at J.P. Morgan Healthcare Conference
Read
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
|
Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
|
